Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: Randomised controlled trial

British Journal of Psychiatry

Volumn 204, Issue 2, 2014, Pages 144-150

  Menchetti, Marco ^a   Rucci, Paola ^b   Bortolotti, Biancamaria ^a   Bombi, Annarosa ^a   Scocco, Paolo ^c   Kraemer, Helena Chmura ^d   Berardi, Domenico ^a   Luciano, Claudia ^a   Lia, Loredana ^a   Manganaro, Dario ^a   Magnani, Michele ^a   Nespeca, Claudia ^a   Succu, Massimo ^a   Bellino, Silvio ^e   Bogetto, Filippo ^e   Zizza, Monica ^e   Colombini, Niccolò ^f   Rigatelli, Marco ^f   Simoni, Elena ^f   Tedeschin, Enrico ^f   Baranzini, Federico ^g   Bortolaso, Paola ^g   Callegari, Camilla ^g   Diurni, Giovanni Croci Marcello ^g   Vender, Simone ^g   Martinelli, Valentina ^h   Politi, Pierluigi ^h   Sciarini, Paola ^h   Piselli, Massimiliano ⁱ   Quartesan, Roberto ⁱ   Bellomo, Antonello ^j   De Salvia, Michela ^j   Ferretti, Madia ^j   Iuso, Salvatore ^j   Petito, Annamaria ^j   Affatati, Valeria ^k   Todarello, Orlando ^k   Carpiniello, Bernardo ^l   Contu, Cecilia ^l   Pinna, Federica ^l   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Local Social Sanitary Unit   (Italy)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g UNIVERSITY OF INSUBRIA   (Italy)

^h UNIVERSITY OF PAVIA   (Italy)

ⁱ UNIVERSITY OF PERUGIA   (Italy)

^j UNIVERSITY OF FOGGIA   (Italy)

^k UNIVERSITY OF BARI   (Italy)

^l UNIVERSITY OF CAGLIARI   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; SERTRALINE;

ADULT; ANXIETY DISORDER; AORK AND SOCIAL ADJUSTMENT SCALE; ARTICLE; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; GENERAL PRACTITIONER; HAMILTON SCALE; HUMAN; INTERPERSONAL COUNSELLING; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICATION COMPLIANCE; META ANALYSIS (TOPIC); MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; SECONDARY ANALYSIS; SMOKING HABIT; SOCIAL ADAPTATION; THERAPY EFFECT; TREATMENT REFUSAL; UNSPECIFIED SIDE EFFECT;

ACTIVITIES OF DAILY LIVING; ADULT; ANXIETY; COUNSELING; DEPRESSIVE DISORDER, MAJOR; EFFECT MODIFIER, EPIDEMIOLOGIC; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, BRIEF; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SMOKING; SOCIAL ADJUSTMENT;

EID: 84893618430     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.112.122663     Document Type: Article

References (41)

1. Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JB, deGruy 3rd FV, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA 1995; 274: 1511-7.
2. Üstun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386-92.
3. Fernández A, Bellón Saameño JA, Pinto-Meza A, Luciano JV, Autonell J, Palao D, et al. Burden of chronic physical conditions and mental disorders in primary care. Br J Psychiatry 2010; 196: 302-9.
4. Lerner D, Adler DA, Chang H, Lapitsky L, Hood MY, Perissinotto C, et al. Unemployment, job retention, and productivity loss among employees with depression. Psychiatr Serv 2004; 55: 1371-8.
5. Davidson Jr. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry 2010; 71 (suppl E1): e04.
6. American Psychiatric Association. Practice Guideline for the Treatment of Major Depression Disorder. APA, 2000.
7. National Institute for Health and Clinical Excellence. Depression: The Treatment and Management of Depression In Adults. Clinical Guideline 90. NICE, 2009.
8. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity SurveyReplication (NCS-R). JAMA 2003; 289: 3095-105.
9. Simon GE, Perlis RH. Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry 2010; 167: 1445-55.
10. Papakostas GI, Fava M. Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues Clin Neurosci 2008; 10: 439-51.
11. Frank E, Cassano GB, Rucci P, Thompson WK, Kraemer HC, Fagiolini A, et al. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychol Med 2011; 41: 151-62.
12. De Rubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005; 62: 409-16.
13. Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006; 74: 658-70.
14. Kocsis JH, Leon AC, Markowitz JC, Manber R, Arnow B, Klein DN, et al. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry 2009; 70: 354-61.
15. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol 2009; 77: 775-87.
16. Menchetti M, Bortolotti B, Rucci P, Scocco P, Bombi A, Berardi D, et al. Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design. BMC Psychiatry 2010; 10: 97.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (suppl 20): 22-33.
19. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-96.
20. Klerman GL, Weissman MM, Rounsaville BJ, Chevron E. Interpersonal Psychotherapy of Depression. Basics Books, 1984.
21. Klerman GL, Budman S, Berwick D, Weissman MM, Damico-White J, Demby A, et al. Efficacy of a brief psychosocial intervention for symptoms of stress and distress among patients in primary care. Med Care 1987; 25: 1078-88.
22. Mossey JM, Knott KA, Higgins M, Talerico K. Effectiveness of a psychosocial intervention, interpersonal counseling, for subdysthymic depression in medically ill elderly. J Gerontol A Biol Sci Med Sci 1996; 51: M172-8.
23. Neugebauer R, Kline J, Bleiberg K, Baxi L, Markowitz JC, Rosing M, et al. Preliminary open trial of interpersonal counseling for subsyndromal depression following miscarriage. Depress Anxiety 2007; 24: 219-22.
24. Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 2002; 180: 461-4.
25. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001; 178: 234-41.
26. McPartlin GM, Reynolds A, Anderson C. A comparison of once daily venlafaxine XR and paroxetine in depressed outpatients treated in general practice. Primary Care Psychiatry 1998; 4: 127-32.
27. Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000; 320: 26-30.
28. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002; 59: 877-83.
29. Pincus T, Miles C, Froud R, Underwood M, Carnes D, Taylor S. Methodological criteria for the assessment of moderators in systematic reviews of randomised controlled trials: a consensus study. BMC Med Res Methodol 2011; 11: 14.
30. Sun X, Briel M, Busse J, You J, Akl E, Mejza F, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ 2012; 344: e1553.
31. Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 2006; 59: 990-6.
32. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995; 310: 441-5.
33. Brown C, Schulberg HC, Madonia MJ, Shear MK, Houck PR. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996; 153: 1293-300.
34. Chilvers C, Dewey M, Fielding K, Gretton V, Miller P, Palmer B, et al. Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ 2001; 322: 772-5.
35. Bortolotti B, Menchetti M, Bellini F, Montaguti MB, Berardi D. Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials. Gen Hosp Psychiatry 2008; 30: 293-302.
36. Brown C, Schulberg HC, Prigerson HG. Factors associated with symptomatic improvement and recovery from major depression in primary care patients. Gen Hosp Psychiatry 2000; 22: 242-50.
37. You S, Conner KR. Stressful life events and depressive symptoms: influences of gender, event severity, and depression history. J Nerv Ment Dis 2009; 197: 829-33.
38. Salminen JK, Karlsson H, Hietala J, Kajander J, Aalto S, Markkula J, et al. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom 2008; 77: 351-7.
39. Hegerl U, Hautzinger M, Mergl R, Kohnen R, Schütze M, Scheunemann W, et al. Effects of pharmacotherapy and psychotherapy in depressed primarycare patients: a randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol 2010; 13: 31-44.
40. Brookes S, Whitely E, Egger M, Davey Smith G, Mulheran P, Peters T. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol 2004; 57: 229-36.
41. Van HL, Schoevers RA, Dekker J. Predicting the outcome of antidepressants and psychotherapy for depression: a qualitative, systematic review. Harv Rev Psychiatry 2008; 16: 225-34.